C. Mautalén

11.7k total citations · 1 hit paper
160 papers, 5.6k citations indexed

About

C. Mautalén is a scholar working on Orthopedics and Sports Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, C. Mautalén has authored 160 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Orthopedics and Sports Medicine, 57 papers in Oncology and 29 papers in Pathology and Forensic Medicine. Recurrent topics in C. Mautalén's work include Bone health and osteoporosis research (70 papers), Bone health and treatments (57 papers) and Vitamin D Research Studies (24 papers). C. Mautalén is often cited by papers focused on Bone health and osteoporosis research (70 papers), Bone health and treatments (57 papers) and Vitamin D Research Studies (24 papers). C. Mautalén collaborates with scholars based in Argentina, United States and Uruguay. C. Mautalén's co-authors include Beatriz Oliveri, Marta G. Ladizesky, A. Bagur, Chris Recknor, Jonathan D. Adachi, Lars Hyldstrup, Kenneth W. Lyles, Lars Nordsletten, Carl F. Pieper and Jay Magaziner and has published in prestigious journals such as New England Journal of Medicine, American Journal of Clinical Nutrition and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

C. Mautalén

157 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

2007 1.4k citations Jonathan D. Adachi, C. Mautalén et al. profile →

Peers

Countries citing papers authored by C. Mautalén

Since Specialization

Citations

This map shows the geographic impact of C. Mautalén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Mautalén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Mautalén more than expected).

Fields of papers citing papers by C. Mautalén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Mautalén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Mautalén. The network helps show where C. Mautalén may publish in the future.

Co-authorship network of co-authors of C. Mautalén

This figure shows the co-authorship network connecting the top 25 collaborators of C. Mautalén. A scholar is included among the top collaborators of C. Mautalén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Mautalén. C. Mautalén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study 2015 ·Osteoporosis International ·Socrates E. Papapoulos, Kurt Lippuner, Christian Roux, Celia J. F. Lin, David L. Kendler, E. Michael Lewiecki, Maria Luisa Brandi, E. J. Czerwiński, Edward Franek, P. Lakatos, C. Mautalén, Salvatore Minisola, Jean‐Yves Reginster, S. Jensen, Nadia Daizadeh, (unknown), Marc A. Gavin, Cesar Libanati, Rachel B. Wagman, Henry G. Bone	203
2	EIGHT YEARS OF DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST FIVE YEARS OF THE FREEDOM EXTENSION 2014 ·Open Repository and Bibliography (University of Liège) ·Socrates E. Papapoulos, Kurt Lippuner, C. Roux, (unknown), (unknown), E. Michael Lewiecki, Maria Luisa Brandi, E. J. Czerwiński, Edward Franek, (unknown), C. Mautalén, Salvatore Minisola, Jean‐Yves Reginster, S. Jensen, Nadia Daizadeh, (unknown), Marc A. Gavin, (unknown), (unknown)	12
3	Romosozumab and Teriparatide Effects on Vertebral Cortical Mass, Thickness, and Density in Postmenopausal Women With Low Bone Mineral Density (BMD). 2014 ·Cambridge University Engineering Department Publications Database ·Tristan Whitmarsh, Graham M. Treece, AH Gee, (unknown), (unknown), Stefan Goemaere, Andreas Grauer, D.A. Hanley, C. Mautalén, Chris Recknor, (unknown), Cesar Libanati, Kenneth Poole	5
4	Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis 2012 ·Menopause The Journal of The North American Menopause Society ·James A. Simon, Christopher Recknor, Alfred H. Moffett, Jonathan D. Adachi, Edward Franek, E. Michael Lewiecki, Michael R. McClung, C. Mautalén, Sergio Ragi-Eis, Geoffrey C. Nicholson, Christian Muschitz, Ranuccio Nuti, Ove Törring, Andrea Wang, Cesar Libanati	32
5	Effects of intravenous ibandronate injection on renal function in women with postmenopausal osteoporosis at high risk for renal disease — The DIVINE study 2011 ·Bone ·Paul D. Miller, Sergio Ragi-Eis, C. Mautalén, Francisco Ramirez, (unknown)	20
6	Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women 2006 ·European Journal of Clinical Nutrition ·Silvina Rosana Mastaglia, C. Mautalén, (unknown), Beatriz Oliveri	32
7	High prevalence of vitamin D insufficiency in healthy elderly people living at home in Argentina 2004 ·European Journal of Clinical Nutrition ·Beatriz Oliveri, Luisa Plantalech, A. Bagur, (unknown), (unknown), Eduardo Pusiol, (unknown), (unknown), (unknown), (unknown), Marta G. Ladizesky, J. Somoza, (unknown), Susana Zeni, (unknown), C. Mautalén	80
8	Ultrasound Parameters and Markers of Bone Turnover in Hyperthyroidism 2004 ·Journal of Clinical Densitometry ·(unknown), Hugo Nièpomniszcze, (unknown), C. Mautalén	5
9	Is it Necessary to Screen for Celiac Disease in Postmenopausal Osteoporotic Women? 2002 ·Calcified Tissue International ·D. González, Emilia Sugai, (unknown), Beatriz Oliveri, (unknown), (unknown), A. Bagur, Roberto M. Mazure, Eduardo Mauriño, Jie Bai, C. Mautalén	39
10	Utilidad clínica de los marcadores de formación y resorción ósea 2001 ·Acta bioquímica clínica latinoamericana ·Susana Zeni, (unknown), Silvana Di Gregorio, (unknown), (unknown), (unknown), (unknown), A. Bagur, Diego González, (unknown), C. Mautalén	10
11	Bone Mineral Density Response to Long-Term Bisphosphonate Therapy in Fibrous Dysplasia 2001 ·Journal of Clinical Densitometry ·(unknown), Beatriz Oliveri, (unknown), C. Mautalén	18
12	Effect of unilateral superior cervical ganglionectomy on bone mineral content and density of rat's mandible 2000 ·Journal of the Autonomic Nervous System ·Marta G. Ladizesky, Rodolfo A. Cutrera, Verónica Boggio, C. Mautalén, Daniel P. Cardinali	21
13	Risk Factors for the Development of Vertebral and Total Skeleton Osteoporosis in Patients with Primary Biliary Cirrhosis 1998 ·Calcified Tissue International ·A. Bagur, C. Mautalén, Jorge Findor, Juan Sordá, J. Somoza	41
14	Hyperthyroidism Influences Ultrasound Bone Measurement on the Os Calcis 1998 ·Osteoporosis International ·(unknown), Anne‐Marie Schott, D. Hans, Hugo Nièpomniszcze, C. Mautalén, P. J. Meunier	22
15	Bone Mineral Density and Bone Size in Men With Primary Osteoporosis and Vertebral Fractures 1998 ·Calcified Tissue International ·Eduardo A. Vega, (unknown), C. Mautalén, (unknown), H.E. Scaglia, (unknown)	84
16	The effect of olpadronate in ovariectomized thyroxine-treated rats 1997 ·Bone ·Susana Zeni, (unknown), C. Mautalén	11
17	Documento final de la conferencia consenso sobre. Quienes son candidatos para la prevencion y tratamiento de la osteoporosis? Amsterdam, 1996 1996 ·(unknown), (unknown), H K Genant, J. A. Kanis, (unknown), (unknown), B. Lawrence Riggs, (unknown), D. M. Hart, Sverker Ljunghall, C. Mautalén, P. J. Meunier, (unknown), (unknown), A Rapado, Jim Stevenson	1
18	[Bone mineral density of the lumbar spine and proximal femur of normal females in Buenos Aires]. 1990 ·PubMed ·C. Mautalén, (unknown), Eduardo A. Vega, (unknown), (unknown)	9
19	[Mineral bone content in a normal population of Buenos Aires]. 1984 ·PubMed ·C. Mautalén, (unknown), (unknown), (unknown)	7
20	Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases. 1984 ·BMJ ·C. Mautalén, (unknown), D. González, (unknown), (unknown), (unknown), Luisa Plantalech	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact